Prelude Therapeutics
PRLD
#8532
Rank
โ‚ฌ0.23 B
Marketcap
2,94ย โ‚ฌ
Share price
-0.77%
Change (1 day)
103.06%
Change (1 year)

Earnings for Prelude Therapeutics (PRLD)

Earnings in 2026 (TTM): -โ‚ฌ57.96 Million

According to Prelude Therapeutics's latest financial reports the company's current earnings are โ‚ฌ22.42 Million. In 2025 the company made an earning of -โ‚ฌ95.33 Million, an increase over its 2024 earnings that were of -โ‚ฌ0.13 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Prelude Therapeutics from 2020 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚ฌ57.96 Million-39.2%
2025 -โ‚ฌ95.33 Million-25.16%
2024 -โ‚ฌ0.13 Billion5.62%
2023 -โ‚ฌ0.13 Billion7.07%
2022 -โ‚ฌ0.12 Billion8.62%
2021 -โ‚ฌ0.11 Billion93.55%
2020 -โ‚ฌ53.57 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ORIC Pharmaceuticals
ORIC
-โ‚ฌ0.15 Billion 131.67%๐Ÿ‡บ๐Ÿ‡ธ USA